Duricef (Cefadroxil)

Do’s

• Take this medication by mouth with or without food as directed by your healthcare provider, usually once or twice a day.
• The dosage is based on your medical condition and response to treatment. In children, the dosage is also based on weight.
• You may take this medication with food if stomach upset occurs.
• If you are using the liquid form of this medication, shake the bottle well before each dose. Carefully measure the dose using a special measuring device/spoon. 
• For optimal results, take this antibiotic at evenly spaced times. To help you remember, take it at the same time(s) every day.
• Continue to take this medication until the full prescribed amount is finished, even if symptoms disappear after a few days. Stopping it too soon may result in a return of the infection.
• Tell your healthcare provider if your condition lasts or gets worse.

Don’ts

• Do not use a household spoon when measuring the liquid form because you may not get the correct dose.

Common Side Effects:

• Vaginal itching or discharge
• Loss of appetite
• Nausea
• Diarrhea
• Headache
• Dizziness
• Fatigue
• Skin rash
• Itching

Serious Side Effects:

• Allergic reaction: rash, itching/swelling (especially of the face/tongue/throat), severe dizziness, trouble breathing
• Severe stomach pain
• Watery or bloody diarrhea
• Fever, chills, body aches, flu symptoms
• Pale skin, easy bruising, unusual bleeding
• Seizures
• Dark-colored urine
• Unusual tiredness or weakness
• Vomiting of blood

This is not a complete list of possible side effects. If you experience any other effects not listed above, contact your healthcare provider. Additionally, if you notice any signs of a serious allergic reaction, seek medical help immediately.

If you are allergic to cefadroxil or other cephalosporin antibiotics, avoid taking Duricef. Inform your healthcare provider about any history of drug allergies, especially to penicillin.

Duricef should be used with caution in individuals with markedly impaired renal function (creatinine clearance rate of less than 50 mL/min/1.73 M2). Close clinical observation and appropriate laboratory studies are recommended before and during therapy in patients with known or suspected renal impairment.

Prescribing Duricef in the absence of a proven or strongly suspected bacterial infection or a prophylactic indication is unlikely to provide benefit and may increase the risk of developing drug-resistant bacteria.

Prolonged use of Duricef may lead to the overgrowth of nonsusceptible organisms. Careful observation of the patient is essential, and appropriate measures should be taken if superinfection occurs during therapy.

Duricef should be prescribed with caution in individuals with a history of gastrointestinal disease, particularly colitis.

This is not an exhaustive list of warnings and precautions associated with Duricef. Always consult a healthcare provider for personalized advice regarding the use of this medication, as individual circumstances may vary.